Nitrosulindac (NCX 1102): A new nitric oxide-donating non-steroidal anti-inflammatory drug (NO-NSAID), inhibits proliferation and induces apoptosis in human prostatic epithelial cell lines

This publication has 36 references indexed in Scilit:

• Aspirin and indomethacin exhibit antiproliferative effects and induce apoptosis in T98G human glioblastoma cells
  Neurological Research, 2003
• Cyclooxygenase‐2 promotes prostate cancer progression
  The Prostate, 2002
• Nitric Oxide-Donating Nonsteroidal Anti-Inflammatory Drugs Inhibit the Growth of Various Cultured Human Cancer Cells: Evidence of a Tissue Type-Independent Effect
  The Journal of Pharmacology and Experimental Therapeutics, 2002
• Antiproliferative Effects of Nitrosulindac on Human Colon Adenocarcinoma Cell Lines
  Biochemical and Biophysical Research Communications, 2001
• Mechanisms of protection and healing: current knowledge and future research
  The American Journal of Medicine, 2001
• The Cyclooxygenase-2 Inhibitor Celecoxib Induces Apoptosis by Blocking Akt Activation in Human Prostate Cancer Cells Independently of Bcl-2
  Journal of Biological Chemistry, 2000
• Suppression of Intestinal Polyposis in ApcΔ716 Knockout Mice by Inhibition of Cyclooxygenase 2 (COX-2)
  Cell, 1996
• Nonsteroidal Antiinflammatory Drugs Inhibit the Proliferation of Colon Adenocarcinoma Cells: Effects on Cell Cycle and Apoptosis
  Experimental Cell Research, 1996
• Chronic Renal Disease and Papillary Necrosis Associated With the Long-Term Use of Nonsteroidal Anti-inflammatory Drugs as the Sole or Predominant Analgesic
  American Journal of Kidney Diseases, 1994
• A new method to detect apoptosis in paraffin sections: in situ end-labeling of fragmented DNA.
  Journal of Histochemistry & Cytochemistry, 1993